Famciclovir
NDC Package 60505-3245-3

11-digit billing NDC: 60505324503 · Billing unit: EA · 30 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Famciclovir is herpes labialis (cold sores)Famciclovir tablets are indicated for the treatment of recurrent herpes labialis. Marketed by Apotex Corp., this product is identified by NDC 60505-3245 and is authorized under FDA application ANDA091480.

Identification & Billing

NDC Package Code
60505-3245-3
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
60505324503
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Famciclovir
Dosage Form
-
Usage Information
Herpes labialis (cold sores)Famciclovir tablets are indicated for the treatment of recurrent herpes labialis.  Genital herpesRecurrent episodesFamciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. The efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. Suppressive therapyFamciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. The efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established.Herpes zoster (shingles) Famciclovir tablets are indicated for the treatment of herpes zoster. The efficacy of famciclovir when initiated more than 72 hours after onset of rash has not been established.

Regulatory & Marketing

Labeler Name
Apotex Corp.
FDA Application #
ANDA091480
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-20-2011
End Marketing Date
05-31-2025
Listing Expiration
05-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60505-3245-3 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Famciclovir, labeled by Apotex Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apotex Corp. on December 20, 2011. The current certification is valid through May 31, 2025.

How is this Apotex Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60505324503. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60505-3245-3
11-Digit CMS (5-4-2)
60505-3245-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.